Yihan Zhang

Ziming Mao, Yihan Zhang, Chihan Cui et al.

Mixture-of-Experts (MoE) workloads rely on expert parallelism (EP) to achieve high GPU efficiency. State-of-the-art EP communication systems such as DeepEP demonstrate strong performance but exhibit poor portability across heterogeneous GPU and NIC platforms. The poor portability is rooted in architecture: GPU-initiated token-level RDMA communication requires tight vertical integration between GPUs and NICs, e.g., GPU writes to NIC driver/MMIO interfaces. We present UCCL-EP, a portable EP communication system that delivers DeepEP-level performance across heterogeneous GPU and NIC hardware. UCCL-EP replaces GPU-initiated RDMA with a high-throughput GPU-CPU control channel: compact token-routing commands are transferred to multithreaded CPU proxies, which then issue GPUDirect RDMA operations on behalf of GPUs. UCCL-EP further emulates various ordering semantics required by specialized EP communication modes using RDMA immediate data, enabling correctness on NICs that lack such ordering, e.g., AWS EFA. We implement UCCL-EP on NVIDIA and AMD GPUs with EFA and Broadcom NICs. On EFA, it outperforms the best existing EP solution by up to $2.1\times$ for dispatch and combine throughput. On NVIDIA-only platform, UCCL-EP achieves comparable performance to the original DeepEP. UCCL-EP also improves token throughput on SGLang by up to 40% on the NVIDIA+EFA platform, and improves DeepSeek-V3 training throughput over the AMD Primus/Megatron-LM framework by up to 45% on a 16-node AMD+Broadcom platform.

Yihan Zhang, Xuanshuo Zhang, Wei Wu et al.

Saliency maps have been widely used to interpret deep learning classifiers for Alzheimer's disease (AD). However, since AD is heterogeneous and has multiple subtypes, the pathological mechanism of AD remains not fully understood and may vary from patient to patient. Due to the lack of such understanding, it is difficult to comprehensively and effectively assess the saliency map of AD classifier. In this paper, we utilize the anatomical segmentation to allocate saliency values into different brain regions. By plotting the distributions of saliency maps corresponding to AD and NC (Normal Control), we can gain a comprehensive view of the model's decisions process. In order to leverage the fact that the brain volume shrinkage happens in AD patients during disease progression, we define a new evaluation metric, brain volume change score (VCS), by computing the average Pearson correlation of the brain volume changes and the saliency values of a model in different brain regions for each patient. Thus, the VCS metric can help us gain some knowledge of how saliency maps resulting from different models relate to the changes of the volumes across different regions in the whole brain. We trained candidate models on the ADNI dataset and tested on three different datasets. Our results indicate: (i) models with higher VCSs tend to demonstrate saliency maps with more details relevant to the AD pathology, (ii) using gradient-based adversarial training strategies such as FGSM and stochastic masking can improve the VCSs of the models.